This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...